Delivery Order SPE2DB22D2214-SPE2DB25FS5WL
- Not listed
- The Defense Logistics Agency awarded a $2,038.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-HC ear suspension (10mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The product will be delivered to the company's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,717.50 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Neomycin-Polymyxin-HC Ear Suspension in 10mL units. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office division. The award...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,735.11 on August 11, 2025, for the supply of Neomycin-Polymyxin-HC Ear Suspension (10mL) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, which is not set-aside, has an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,532.22 to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-Gramicidin eye drops (10mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support military and federal healthcare systems'...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,356.62 delivery order on September 3, 2025, for the supply of Neomycin-Poly-HC eye drops in 7.5ml quantities. This firm fixed price, non-set-aside contract is expected to be completed by September 4, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ofloxacin 0.3% ear drops in 5 mL quantities, with a ceiling value of $2,193.80. This is a firm fixed-price delivery order under a non-competitive set-aside arrangement, with an ultimate completion date of June 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Department, through its Medical Supply Chain, awarded a delivery order valued at $1,228.82 to AmerisourceBergen Drug Corp for the supply of Neomycin/Polymyxin B, an antibiotic combination product. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 23, 2025. This delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,523.65 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a small-value pharmaceutical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,457.41 for Hydrocortisone-Acetic Ear Drop (10mL) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5WLDelivery Order
The Defense Logistics Agency awarded a $2,707.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-HC Ear Suspension (10mL) on July 23, 2025, with completion expected by July 24, 2025. This award is a non-competitive delivery order issued under an existing contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The pharmaceutical product supplied under this delivery order serves medical supply needs within the federal healthcare system, supporting military and defense-related medical operations. This delivery order is a child action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen demonstrates significant capacity to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/23/25 |